A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

SPIRA-P and SPIRA-T Devices Enter Full National Launch Mode Reports Camber Spine

Camber Spine, a leading innovator in spine and medical technologies has announced that it is entering into the next phase of the complete national launch of the SPIRA-P Posterior Lumbar Spacer and has recently commercialized its Spira-T Oblique Posterior Lumbar Spacer.

Part of Camber’s SPIRA product platform, the SPIRA-P Posterior Lumbar Spacer is versatile to accommodate open and minimally invasive PLIF or TLIF procedures and features a patented open architecture design for optimal endplate load distribution. Additionally, its uniquely designed surface allows for cell adhesion and bone cell proliferation while its interconnected porosity design mimics bone.

The SPIRA-T Oblique Posterior Lumbar Spacer is designed specifically to accommodate traditional and “insert and rotate” TLIF procedures.  SPIRA-T is designed  to efficiently accommodate an oblique approach  and to optimize segmental lordosis.

As with all products within Camber’s SPIRA technology platform, SPIRA-P and SPIRA-T include strategically placed and optimal sized openings for graft packing. The SPIRA products are designed to decrease the risk of subsidence with optimized endplate distribution and provide good visibility for fusion.

SPIRA-P and SPIRA-T will be among the systems displayed at Camber’s booth (#302) this week at the International Society for the Advancement of Spine Surgery (ISASS) Annual Meeting at the Atlantis Hotel in the Bahamas. Camber’s booth will also be hosting a series of focus sessions:

 

  • “The Solution to the Posterior Approach”
  • “The Anterior Column Solution”
  • “The Advanced Biologics Solution”

SPIRA implants are 3D printed. This specialized manufacturing technology allows Camber to create unique patented structures featuring open arched matrices and proprietary surfaces designed to enhance fusion and promote bone growth.

“We are excited to continue to make our SPIRA-P technology available to more surgeons around the country,” said Camber Co-Founder and CEO, Daniel Pontecorvo, “Providing structural stability following discectomy, our SPIRA Posterior Lumbar Spacers have different shapes and designs to accommodate a broader array of posterior and transforaminal approaches and techniques.”

With further expansions to its lines of award-winning SPIRA and ENZA technology platforms due later this year, along with training labs and educational programs to support ALIF, LLIF, OLIF, PLIF and TLIF spine surgery techniques, the company is focused on fulfilling its mission to support the full array of surgical approaches.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy